REPATHA 140 mg/mL
Evolocumab · INJECTION, SOLUTION · Amgen USA Inc.
No Recall History
Plain English
REPATHA is a injection, solution containing evolocumab at 140 mg/mL, taken subcutaneous. Manufactured by Amgen USA Inc..
Key Facts
- Brand Name
- REPATHA
- Generic Name
- Evolocumab
- NDC Code (Product)
72511-760- Manufacturer
- Amgen USA Inc.
- Strength
- 140 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125522
- Drug Class
- PCSK9 Inhibitor [EPC]
- Marketing Start
- 10/09/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is REPATHA used for?
REPATHA contains Evolocumab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is REPATHA a controlled substance?
REPATHA is not classified as a controlled substance by the DEA.
What is the generic name for REPATHA?
The generic name for REPATHA is Evolocumab. There are no other listed brand versions of Evolocumab.
What is the NDC code for REPATHA 140 mg/mL?
The NDC (National Drug Code) for REPATHA 140 mg/mL is 72511-760, listed by Amgen USA Inc..
Other REPATHA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)